Avançar para navegação principal Avançar para pesquisar Avançar para conteúdo principal

The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules

Resultado de pesquisa: ???type-name??????researchoutput.researchoutputtypes.contributiontojournal.systematicreview???revisão de pares

119 Citações (Scopus)

Resumo

Oxindole derivatives are known for their great interest in the field of Medicinal Chemistry, as they display vast biological activities. Recent efforts concerning the preparation of oxindole derivatives using isatin-based multicomponent reactions (MCRs) constitute a great advance in generating druglike libraries fast and with wide scaffold diversity. In this review, we address those recent developments, exploring the synthetic pathways and biological activities described for these compounds, namely antitumor, antibacterial, antifungal, antiparasitic, antiviral, antioxidant, anti-inflammatory and central nervous system (CNS) pathologies. To add new depth to this work, we used a well-established web-based free tool (SwissADME) to evaluate the most promising scaffolds in what concerns their druglike properties, namely by evaluating their compliance with some of the most valuable rules applied by medicinal chemists in both academia and industrial settings (Lipinski, Ghose, Veber, Egan, Muegge). The aim of this review is to endorse isatin-based MCRs as a valuable synthetic approach to attain new hit compounds bearing the oxindole privileged structure, while critically exploring these scaffolds’ druglike properties.

Idioma original???core.languages.en_GB???
Número do artigo113102
RevistaEuropean Journal of Medicinal Chemistry
Volume211
DOIs
Estado da publicação???researchoutput.status.published??? - 5 fev. 2021
Publicado externamenteSim

Impressão digital

Mergulhe nos tópicos de investigação de “The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules“. Em conjunto formam uma impressão digital única.

Citar isto